{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:15:36Z","timestamp":1790720136872,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jaac.2016.02.016","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T10:02:31Z","timestamp":1457344951000},"page":"415-423","source":"Crossref","is-referenced-by-count":73,"title":["Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder"],"prefix":"10.1016","volume":"55","author":[{"given":"Lawrence","family":"Scahill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangchoon","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Boorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"McDougle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Aman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Dziura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"McCracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Caprio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Eugene","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginger","family":"Nicol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saankari A.","family":"Challa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetto","family":"Vitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2016.02.016_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2016.02.016_bib2","doi-asserted-by":"crossref","first-page":"e634","DOI":"10.1542\/peds.2003-0264-F","article-title":"Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders","volume":"114","author":"Shea","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2016.02.016_bib3","series-title":"Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text rev","year":"2000"},{"key":"10.1016\/j.jaac.2016.02.016_bib4","first-page":"1142","article-title":"Risperidone treatment of autistic disorder: longer term benefits and blinded discontinuation after six months","volume":"162","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2016.02.016_bib5","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/01.chi.0000177055.11229.76","article-title":"Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study","volume":"44","author":"Troost","year":"2005","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2016.02.016_bib6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1176\/appi.ajp.161.6.1125","article-title":"Weight and leptin changes among risperidone-treated youths with autism: 6-month perspective data","volume":"161","author":"Martin","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2016.02.016_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/cap.2006.16.575","article-title":"Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy","volume":"16","author":"Luby","year":"2006","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2016.02.016_bib8","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2016.02.016_bib9","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1038\/tp.2013.26","article-title":"Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies","volume":"3","author":"Nurmi","year":"2013","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jaac.2016.02.016_bib10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1399-5448.2008.00504.x","article-title":"Obesity dynamics and cardiovascular risk factor stability in obese adolescents","volume":"10","author":"Weiss","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jaac.2016.02.016_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000354662","article-title":"Insulin resistance and cardiovascular risk factors in 3- to 5-year-old overweight or obese children","volume":"80","author":"Bocca","year":"2013","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.jaac.2016.02.016_bib12","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1056\/NEJMoa031049","article-title":"Obesity and the metabolic syndrome in children and adolescents","volume":"350","author":"Weiss","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2016.02.016_bib13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.21262","article-title":"NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice","volume":"44","author":"Nobili","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jaac.2016.02.016_bib14","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamapsychiatry.2013.2053","article-title":"Antipsychotics and the risk of type 2 diabetes mellitus in children and youth","volume":"70","author":"Bobo","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jaac.2016.02.016_bib15","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1210\/jc.2006-0733","article-title":"Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome","volume":"91","author":"Winer","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"10.1016\/j.jaac.2016.02.016_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/2047-783X-15-S2-147","article-title":"Adiponectin as a biomarker of the metabolic syndrome in children and adolescents","volume":"15","author":"Pyrzak","year":"2010","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jaac.2016.02.016_bib17","first-page":"2380","article-title":"Revisiting leptin\u2019s role in obesity and weight loss","volume":"118","author":"Ahima","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaac.2016.02.016_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40272-013-0016-6","article-title":"Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis","volume":"15","author":"Almandil","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jaac.2016.02.016_bib19","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/CHI.0b013e3181bfd669","article-title":"Research Units on Pediatric Psychopharmacology Autism Network. Medication and parent training in children with pervasive developmental disorders and serious behavior problems","volume":"48","author":"Aman","year":"2009","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2016.02.016_bib20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaac.2011.11.010","article-title":"Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems","volume":"51","author":"Scahill","year":"2012","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2016.02.016_bib21","first-page":"492","article-title":"Psychometric characteristics of the Aberrant Behavior Checklist","volume":"89","author":"Aman","year":"1985","journal-title":"Am J Ment Defic"},{"key":"10.1016\/j.jaac.2016.02.016_bib22","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10803-013-1970-0","article-title":"Validity of the Aberrant Behavior Checklist in children with autism spectrum disorder","volume":"44","author":"Kaat","year":"2014","journal-title":"J\u00a0Autism Dev Disord"},{"key":"10.1016\/j.jaac.2016.02.016_bib23","series-title":"Vineland II: Vineland Adaptive Behavior Scales, Second Edition: Survey Forms Manual","author":"Sparrow","year":"2005"},{"key":"10.1016\/j.jaac.2016.02.016_bib24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF02172145","article-title":"Autism Diagnostic Interview\u2013revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders","volume":"24","author":"Lord","year":"1994","journal-title":"J\u00a0Autism Dev Disord"},{"key":"10.1016\/j.jaac.2016.02.016_bib25","series-title":"Growth at Adolescence","author":"Tanner","year":"1962"},{"key":"10.1016\/j.jaac.2016.02.016_bib26","first-page":"1","article-title":"2000 CDC Growth Charts for the United States: methods and development","volume":"246","author":"Kuczmarski","year":"2002","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.jaac.2016.02.016_bib27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.114.2.S2.555","article-title":"The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2016.02.016_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jpeds.2004.06.044","article-title":"Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents","volume":"145","author":"Fernandez","year":"2004","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaac.2016.02.016_bib29","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1399-5448.2008.00406.x","article-title":"The triglyceride\/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors","volume":"9","author":"Quijada","year":"2008","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jaac.2016.02.016_bib30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2337\/dc11-1456","article-title":"Usefulness of the high triglyceride-to-HDL cholesterol ratio to identify cardiometabolic risk factors and preclinical signs of organ damage in outpatient children","volume":"35","author":"Di Bonito","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaac.2016.02.016_bib31","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1056\/NEJMoa012578","article-title":"Prevalence of impaired glucose tolerance among children and adolescents with marked obesity","volume":"346","author":"Sinha","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2016.02.016_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1542\/peds.2008-1349","article-title":"Lipid screening and cardiovascular health in childhood","volume":"122","author":"Daniels","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2016.02.016_bib33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","article-title":"IDF Consensus Group. The metabolic syndrome in children and adolescents\u2014an IDF consensus report","volume":"8","author":"Zimmet","year":"2008","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jaac.2016.02.016_bib34","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/JCP.0b013e31822befa9","article-title":"The effect of long-term use of risperidone on body weight of children with an autism spectrum disorder","volume":"31","author":"Demb","year":"2011","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jaac.2016.02.016_bib35","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaac.2014.08.009","article-title":"Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naive patients","volume":"53","author":"Arango","year":"2014","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2016.02.016_bib36","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1542\/peds.2008-3782","article-title":"A\u00a0multicenter, double-blind, randomized, placebo controlled, flexible-dose, parallel-group study of aripiprazole in the treatment of irritability in children and adolescents (6\u201317 years) with autistic disorder","volume":"124","author":"Owen","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2016.02.016_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1089\/cap.2013.0099","article-title":"Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazole","volume":"24","author":"Wink","year":"2014","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2016.02.016_bib38","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.biopsych.2012.01.014","article-title":"A\u00a0randomized controlled pilot trial of oral N-acetylcysteine in children with autism","volume":"71","author":"Hardan","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaac.2016.02.016_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/609705","article-title":"Effectiveness of methylcobalamin and folinic acid treatment on adaptive behavior in children with autistic disorder is related to glutathione redox status","author":"Frye","year":"2013","journal-title":"Autism Res Treat"},{"key":"10.1016\/j.jaac.2016.02.016_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jaba.30","article-title":"Thirty years of research on the functional analysis of problem behavior","volume":"46","author":"Beavers","year":"2013","journal-title":"J\u00a0Appl Behav Anal"},{"key":"10.1016\/j.jaac.2016.02.016_bib41","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/jama.2015.3150","article-title":"Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: a randomized clinical trial","volume":"313","author":"Bearss","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2016.02.016_bib42","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpediatrics.2010.48","article-title":"Metabolic screening in children receiving antipsychotic drug treatment","volume":"164","author":"Morrato","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jaac.2016.02.016_bib43","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1111\/j.2047-6310.2012.00073.x","article-title":"Adiposity in children and adolescents: correlates and clinical consequences of fat stored in specific body depots","volume":"7","author":"Katzmarzyk","year":"2012","journal-title":"Pediatr Obes"},{"key":"10.1016\/j.jaac.2016.02.016_bib44","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1038\/sj.npp.1301392","article-title":"Adiposity and insulin sensitivity from intravenous glucose tolerance tests in antipsychotic-treated patients","volume":"32","author":"Haupt","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jaac.2016.02.016_bib45","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1210\/jc.2010-1047","article-title":"Insulin resistance in children: consensus, perspective, and future directions","volume":"95","author":"Levy-Marchal","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jaac.2016.02.016_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2012.08.036","article-title":"Functional and structural features of adipokine family","volume":"61","author":"Raucci","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.jaac.2016.02.016_bib47","first-page":"482","article-title":"Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial","volume":"25","author":"Aman","year":"2015","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856716300429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856716300429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T19:52:13Z","timestamp":1600285933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856716300429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0890856716300429"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2016.02.016","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}